No recent analyst price targets found for SOBI.ST.
Latest News for SOBI.ST

Sobi receives complete response letter from FDA for NASP (nanoencapsulated sirolimus plus pegadricase)
/PRNewswire/ --The FDA has requested additional data related to chemistry, manufacturing, and controls (CMC) and contract manufacturing facilities; no clinical
PRNewsWire • Jun 26, 2026

Sobi receives complete response letter from FDA for NASP (nanoencapsulated sirolimus plus pegadricase)
/PRNewswire/ --The FDA has requested additional data related to chemistry, manufacturing, and controls (CMC) and contract manufacturing facilities; no clinical
PRNewsWire • Jun 26, 2026
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for SOBI.ST.
Senate Trading
No Senate trades found for SOBI.ST.
U.S. House Trading
No House trades found for SOBI.ST.
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Bid/Ask/Mark (first):
Core Metrics:
More Greeks (optional):
Valuation:
Price & Momentum:
IV Variants:
IV Units:
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
